AZ seeks FDA okay for first self-administered flu vaccine
pharmaphorum
OCTOBER 24, 2023
AZ seeks FDA okay for first self-administered flu vaccine Phil.
Sat.Oct 21, 2023 - Fri.Oct 27, 2023
111 
Amgen plans to lay off 350 former Horizon employees after $28B buyout
Fierce Pharma
OCTOBER 24, 2023
In the biopharma industry, post-merger layoffs are often a question of when and how many. | In the biopharma industry, post-merger layoffs are often a question of when and how many. In the case of Amgen’s $27.8 billion buyout of Horizon, they came quickly. Around 350 former Horizon employees are being told this week that their positions will be eliminated.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The Data Tsunami is Here—And it’s Time for “Smart” Views of Clinical Data
MedCity News
OCTOBER 25, 2023
The healthcare industry must prioritize the development and implementation of universal tools that can efficiently navigate, interpret, and derive value from the growing wealth of health data.
Patient groups have become a powerhouse in R&D. Here’s a look at their impact.
PharmaVoice
OCTOBER 25, 2023
“They have the money,” and they’re using it to influence drug development, according to the executive director of the IQVIA Institute for Human Data Science.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Local authorities in England are failing to meet dementia diagnosis targets
PharmaTimes
OCTOBER 25, 2023
The APPG has called for urgent improvements in rural and ethnically diverse-areas - News - PharmaTimes
Novartis claims ex-staffer jumped to Takeda with 'thousands' of sensitive files
Fierce Pharma
OCTOBER 26, 2023
Novartis believes a former employee of its Egyptian affiliate made off with thousands of files before jumping ship to Takeda. | Novartis believes a former employee of its Egyptian affiliate made off with thousands of files before jumping ship to Takeda. Now, the Swiss pharma giant wants a peek at Takeda’s business records to find out whether its confidential information has been used improperly.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Rescheduling Cannabis to a Schedule III Controlled Substance: A Regulator’s Perspective
PM360
OCTOBER 25, 2023
On August 30, the U.S. Department of Health and Human Services (HHS) made a recommendation to the U.S. Drug Enforcement Administration (DEA) that cannabis be moved from a Schedule I Controlled Substance to a Schedule III Controlled Substance under the federal Controlled Substances Act. While a great deal has been speculated about the potential impact of rescheduling on state licensed cannabis businesses, pharmaceutical companies, health plans, insurance companies, and federal agencies such as th
NHS virtual wards to treat heart failure patients at home
PharmaTimes
OCTOBER 26, 2023
Thousands of patients with heart failure are set to benefit from the expansion - News - PharmaTimes
Sanofi CEO Hudson's new 'Play to Win' pivot sends stock plunging
Fierce Pharma
OCTOBER 27, 2023
Sanofi acolytes are none too happy with the latest chapter of CEO Paul Hudson’s "Play to Win" strategy. | Sanofi acolytes are none too happy with the latest chapter of CEO Paul Hudson’s "Play to Win" strategy. After unveiling the pivot alongside third-quarter earnings Friday, Sanofi’s stock plunged nearly 20%, with one analyst group suggesting the plan came “at the wrong time.
Why Telehealth is Vital for Addressing the Children’s Mental Health Crisis Affecting Emergency Departments Nationwide
MedCity News
OCTOBER 26, 2023
In a recent call for action, leading medical bodies agree that telehealth is integral to providing accessible and equitable mental health care for children.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
COVID, flu combo jab from Pfizer/BioNTech heads for phase 3
pharmaphorum
OCTOBER 26, 2023
COVID, flu combo jab from Pfizer/BioNTech heads for phase 3 Phil.
AstraZeneca granted licence for Nanoform’s AI technology
PharmaTimes
OCTOBER 23, 2023
STARMAP will accelerate the selection of AZ’s best molecule candidates - News - PharmaTimes
Eisai, Biogen's injectable Leqembi clears toxic protein in Alzheimer's disease. What about safety?
Fierce Pharma
OCTOBER 26, 2023
With concerns growing over the burden Leqembi could impose on healthcare infrastructure, Eisai and Biogen have trotted out data for an under-the-skin version of the Alzheimer’s disease drug that ma | Eisai and Biogen have trotted out data for a subcutaneous version of the Alzheimer’s disease drug Leqembi. The self-injected version showed an encouraging efficacy result but a seemingly increased risk of ARIA, which analysts said shouldn't be too much of a concern.
Beyond the Bedside: Strengthening Patient-Physician Bonds Through Virtual Care
MedCity News
OCTOBER 27, 2023
While some people question how virtual care can be effective without physical touch, it is clear that in-person appointments are not frequently delivering on developing a comprehensive understanding of a patient’s need and holistic health.
Europe’s pharmaceutical packaging market to value over $35bn by 2028
European Pharmaceutical Review
OCTOBER 24, 2023
Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2028, according to a report by Arizton. Having been valued at $27.04 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028. Europe’s position in the global pharmaceutical packaging and labelling market The authors highlighted that Europe led the worldwide market at 27 percent in 2022.
ADDF announces speech database to identify biomarkers for Alzheimer’s
Pharmaceutical Technology
OCTOBER 24, 2023
SpeechDx will contain recorded voice samples and other data, which will be used to develop algorithms for creating new speech biomarkers.
Eli Lilly enters crowded ulcerative colitis market with delayed FDA approval for Omvoh
Fierce Pharma
OCTOBER 27, 2023
Weight loss contender Mounjaro may be getting Eli Lilly a lot of public attention these days, but the Indiana pharma giant is busy expanding in immunology, too. | Weight loss contender Mounjaro may be getting Eli Lilly a lot of public attention these days, but the Indiana pharma giant is busy expanding in immunology, too.
Finding a Collaborative, Data-Driven Future for Pharma
MedCity News
OCTOBER 24, 2023
The future of pharmaceutical innovation hinges on enhanced data discovery and collaboration. Through data sharing and collective effort, the pharmaceutical industry can accelerate the development of new therapies.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Sanofi will exit consumer health and boost R&D investment
pharmaphorum
OCTOBER 27, 2023
Sanofi will exit consumer health and boost R&D investment Phil.
Parkinson’s UK awards over £1.8m for nine research projects
PharmaTimes
OCTOBER 27, 2023
Around 145,000 people in the UK are living with Parkinson’s disease - News - PharmaTimes
ESMO: Merck, in flurry of studies, shows Keytruda's power and limitations
Fierce Pharma
OCTOBER 24, 2023
At this year’s congress of the European Society for Medical Oncology (ESMO), Merck & Co. unleashed a flurry of studies showing Keytruda’s power across multiple tumor types. | Across four separate studies, Merck’s PD-1 juggernaut Keytruda—in combination with other cancer meds—charted complete and partial wins in cervical cancer, early breast cancer and stomach cancer.
2.3M People Would Gain Coverage If Remaining 10 States Expanded Medicaid
MedCity News
OCTOBER 23, 2023
If the remaining 10 states expanded Medicaid, uninsured rates would greatly drop for women of reproductive age, non-Hispanic Black adults and young adults, a new Urban Institute report found.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
3 Ways AI is Already Changing Advertising (and None Are Generative AI)
PM360
OCTOBER 25, 2023
Everyone’s buzzing about generative artificial intelligence (AI), and it’s true that technology like ChatGPT is already having an enormous impact on advertising and marketing. But other AI tools that our industry has been using for years have changed the face of media planning and buying. The examples below share how we have been utilizing AI for our pharma clients.
FDA grants clearance for Endogena’s age-related macular degeneration treatment
PharmaTimes
OCTOBER 25, 2023
The company will launch a clinical investigation of EA-2351 for geographic atrophy - News - PharmaTimes
With FDA rejection to treat hives disorder, Sanofi and Regeneron's Dupixent suffers rare setback
Fierce Pharma
OCTOBER 23, 2023
Regeneron and Sanofi are anxious to bring Dupixent as an answer for chronic spontaneous urticaria (CSU), a severe inflammatory condition that causes hives and deep swelling on or under the skin.
How Tech Changes to Clinical Trials Help Both Patients and Biopharma Firms
MedCity News
OCTOBER 27, 2023
Technology is transforming how clinical trials are run. A panel during MedCity News’ INVEST Digital Health conference discussed the tech trends shaping the design and execution of drug studies.
How to Stay Competitive in the Evolving State of Martech
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
An ‘inverse vaccine’ takes aim at autoimmune diseases
PharmaVoice
OCTOBER 23, 2023
Backed by Pfizer, Anokion’s innovative approach to treating celiac, MS and more is showing early promise where others failed.
NICE backs pump-based Parkinson’s drug from AbbVie
pharmaphorum
OCTOBER 26, 2023
NICE backs pump-based Parkinson’s drug from AbbVie Phil.
UPDATED ESMO: Seagen, Astellas and Merck knock it out of the park with Padcev-Keytruda combo in bladder cancer
Fierce Pharma
OCTOBER 22, 2023
Lennon and McCartney. Simon and Garfunkel. Richards and Jagger. Padcev and Keytruda? Can the cancer-fighting duo rock on in bladder cancer? | The results are in for a phase 3 bladder cancer trial assessing the combination of Seagen and Astellas' Padcev, plus Merck's Keytruda, versus standard of care chemotherapy. The figures indicate that the combo can be transformative in the indication.
Heard at HLTH 2023: Execs Share Progress on Digital Health for Pharma, Hospitals, and Behavioral Health Care Coordination [Sponsored]
MedCity News
OCTOBER 23, 2023
In the second part of the Heard at HLTH series, executives from BrightInsight, Iodine Software, Intelligent Medical Objects, Carrum Health, Clarify Health and Trayt Health shared new developments across their businesses and perspectives on value-based care at the HLTH 2023 event.
Let's personalize your content